Marc L. Hyer

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR”.

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR

Nature Communications(2025)10.1038/s41467-025-58183-w

N/A

0.477DataRank · unranked

23 citations

Erin George, David Gallo, Sergey Medvedev, Xiaolei Wang, Arindam Datta +15 more

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0564

N/A

0.470DataRank · unranked

22 citations

Beom-Jun Kim, Aparna Mitra, Craig T. Vollert, Jonathan T. Lei, Diana Fandino +18 more

Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004644

N/A

0DataRank · unranked

34 citations

Akane Yamamichi, Tiffany Chen, Rohini Narayanaswamy, Sébastien Ronseaux, Christine C. Hudson +11 more

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR

Research Square(2024)10.21203/rs.3.rs-3854682/v1

N/A

0DataRank · unranked

3 citations

Haineng Xu, Erin Geroge, David Gallo, Sergey Medvedev, Xiaolei Wang +13 more